MEI Pharma Inc. (Nasdaq: MEIP) has successfully closed a $100 million private placement for the purchase and sale of 29,239,767 shares of common stock at a price of $3.42 per share. This transaction supports MEI's initiative to implement a Litecoin Treasury Strategy, making it the first publicly traded company to adopt Litecoin as a primary treasury reserve asset. As part of this strategic move, MEI has appointed Charlie Lee, the creator of Litecoin, to its Board of Directors and has engaged GSR as its digital asset and treasury management advisor. The funds will be used to acquire Litecoin, enhancing MEI's cash management framework with a decentralized monetary asset. Titan Partners Group served as the sole placement agent for this transaction.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.